{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:05:39Z","timestamp":1790057139711,"version":"4.0.1"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma and remains highly heterogeneous in prognosis. Palmitoylation, an important post-translational modification, has been implicated in tumor biology, but its role in DLBCL, particularly in relation to the immune microenvironment, remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptomic and clinical data from 706 patients with DLBCL were obtained from the Gene Expression Omnibus database. Prognosis-associated palmitoylation-related genes were identified by differential expression and univariate Cox regression analyses. An optimal prognostic model was developed by comparing 101 machine learning algorithm combinations and was further integrated with clinical variables to construct a nomogram. The tumor immune microenvironment was evaluated using immune infiltration, immune function, immune checkpoint, and Tumor Immune Dysfunction and Exclusion analyses. Weighted gene co-expression network analysis (WGCNA) and Mendelian randomization (MR) were performed to identify key genes, followed by experimental validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A 33-gene palmitoylation-related signature (PRS) was established and evaluated across multiple cohorts. PRS was an independent prognostic factor of DLBCL and showed consistent prognostic performance across datasets. Low-risk patients showed higher immune cell infiltration and more active immune function, whereas high-risk patients showed a greater predicted potential to respond to immune checkpoint inhibitor therapy. A nomogram integrating PRS with clinical characteristics also showed favorable predictive accuracy. In addition, two palmitoylation-related molecular subtypes with distinct transcriptomic features, survival outcomes, and immune microenvironment characteristics were identified in DLBCL.\n                      <jats:italic>CEACAM3<\/jats:italic>\n                      was prioritized as a key candidate gene based on integrated WGCNA and MR analyses, and functional experiments showed that\n                      <jats:italic>CEACAM3<\/jats:italic>\n                      knockdown suppressed proliferation and invasion and promoted apoptosis, whereas\n                      <jats:italic>CEACAM3<\/jats:italic>\n                      overexpression enhanced proliferation and invasion, reduced apoptosis, and promoted tumor growth.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The PRS captures prognostic heterogeneity and distinct immune microenvironment features in DLBCL. PRS may provide a useful tool for risk stratification, and\n                      <jats:italic>CEACAM3<\/jats:italic>\n                      may serve as a potential biomarker and therapeutic target in DLBCL.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1907503","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:40:46Z","timestamp":1790055646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A palmitoylation-related signature predicts prognosis and immune microenvironment features in diffuse large B-cell lymphoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Tumor Hospital of Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, School of Medicine, Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030835","article-title":"The immunology of DLBCL","volume":"15","author":"Takahara","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70602","article-title":"A mitochondria-related signature in diffuse large B-cell lymphoma: Prognosis, immune and therapeutic features","volume":"14","author":"Zhou","year":"2025","journal-title":"Cancer Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100750","article-title":"How I treat diffuse large B-cell lymphoma","volume":"8","author":"Melchardt","year":"2023","journal-title":"ESMO Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13543784.2021.1855140","article-title":"Investigational drugs for the treatment of diffuse large B-cell lymphoma","volume":"30","author":"Patriarca","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05880-z","article-title":"Advances in biology, diagnosis and treatment of DLBCL","volume":"103","author":"Shi","year":"2024","journal-title":"Ann Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2016.11.005","article-title":"Exploitation of gene expression and cancer biomarkers in paving the path to era of personalized medicine","volume":"15","author":"Kamel","year":"2017","journal-title":"Genomics Proteomics Bioinf"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188513","article-title":"The clinical relevance of gene expression based prognostic signatures in colorectal cancer","volume":"1875","author":"Ahluwalia","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.691676","article-title":"A novel risk model based on lipid metabolism-associated genes predicts prognosis and indicates immune microenvironment in breast cancer","volume":"9","author":"Ye","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846666","article-title":"Protein palmitoylation and cancer","volume":"19","author":"Ko","year":"2018","journal-title":"EMBO Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s1535-6108(04)00055-8","article-title":"The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer","volume":"5","author":"Graner","year":"2004","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.13308","article-title":"Protein palmitoylation in cancer: Molecular functions and therapeutic potential","volume":"17","author":"Zhou","year":"2023","journal-title":"Mol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2008.97","article-title":"Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer","volume":"88","author":"Fiorentino","year":"2008","journal-title":"Lab Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.14.6475","article-title":"Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase","volume":"7","author":"Di Vizio","year":"2008","journal-title":"Cell Cycle"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.05.059","article-title":"17Beta-estradiol induces ERbeta up-regulation via p38\/MAPK activation in colon cancer cells","volume":"359","author":"Caiazza","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70544","article-title":"ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance","volume":"18","author":"Huang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02130-5","article-title":"Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma","volume":"38","author":"Liu","year":"2024","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41419-020-03311-1","article-title":"GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1599769","article-title":"Comprehensive analysis of palmitoylation-related proteins for prognostic risk evaluation and tumor immune microenvironment assessment in glioma","volume":"16","author":"Xue","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12672-026-04538-8","article-title":"Construction of a prognostic model and multidimensional analysis of hepatocellular carcinoma based on palmitoylation-related genes","volume":"17","author":"Zhang","year":"2026","journal-title":"Discov Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s12672-025-03804-5","article-title":"Unveiling the role of protein palmitoylation in gastric cancer diagnosis via machine learning","volume":"16","author":"Shen","year":"2025","journal-title":"Discov Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat Protoc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-367","article-title":"A flexible R package for nonnegative matrix factorization","volume":"11","author":"Gaujoux","year":"2010","journal-title":"BMC Bioinf"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-14","article-title":"Allowing for mandatory covariates in boosting estimation of sparse high-dimensional survival models","volume":"9","author":"Binder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxu010","article-title":"Random survival forests for competing risks","volume":"15","author":"Ishwaran","year":"2014","journal-title":"Biostatistics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/bioinformatics\/btu660","article-title":"Deviance residuals-based sparse PLS and sparse kernel PLS regression for censored data","volume":"31","author":"Bastien","year":"2015","journal-title":"Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"E108","DOI":"10.1371\/journal.pbio.0020108","article-title":"Semi-supervised methods to predict patient survival from gene expression data","volume":"2","author":"Bair","year":"2004","journal-title":"PloS Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btab869","article-title":"Efficient gradient boosting for prognostic biomarker discovery","volume":"38","author":"Li","year":"2022","journal-title":"Bioinformatics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/bioinformatics\/btq617","article-title":"Improved performance on high-dimensional survival data by application of Survival-SVM","volume":"27","author":"Van Belle","year":"2011","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/atm.2017.04.01","article-title":"Drawing nomograms with R: Applications to categorical outcome and survival data","volume":"5","author":"Zhang","year":"2017","journal-title":"Ann Transl Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v050.i11","article-title":"Evaluating random forests for survival analysis using prediction error curves","volume":"50","author":"Mogensen","year":"2012","journal-title":"J Stat Softw"},{"key":"B35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-025-01738-7","article-title":"Recent advances in S-palmitoylation and its emerging roles in human diseases","volume":"18","author":"Shang","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03393-9","article-title":"Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature","volume":"20","author":"He","year":"2022","journal-title":"J Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"102102","DOI":"10.1016\/j.tranon.2024.102102","article-title":"Predicting lymphoma prognosis using machine learning-based genes associated with lactylation","volume":"49","author":"Zhu","year":"2024","journal-title":"Transl Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1092678","article-title":"Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction","volume":"13","author":"Wu","year":"2022","journal-title":"Front Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e41007","article-title":"Prognostic model based on M2 macrophage-related signatures for predicting outcomes, enhancing risk stratification, and providing therapeutic insights in diffuse large B-cell lymphoma","volume":"10","author":"Guo","year":"2024","journal-title":"Heliyon"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.846357","article-title":"Identification and validation of a prognostic prediction model in diffuse large B-cell lymphoma","volume":"13","author":"Yan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1070777","article-title":"A glycolysis-related gene signatures in diffuse large B-cell lymphoma predicts prognosis and tumor immune microenvironment","volume":"11","author":"Cui","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1037716","article-title":"Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1542829","article-title":"Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphoma","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3334522","article-title":"Identification of aging-related genes associated with prognostic value and immune microenvironment characteristics in diffuse large B-cell lymphoma","volume":"2022","author":"Luo","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.3505","article-title":"Key aspects of prognostic model development and interpretation from a clinical perspective","volume":"148","author":"Hoesseini","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217385","article-title":"Tumor microenvironment: Nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy","volume":"611","author":"Yu","year":"2024","journal-title":"Cancer Lett"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-022-09872-y","article-title":"An M0 macrophage-related prognostic model for hepatocellular carcinoma","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.14712\/18059694.2016.63","article-title":"Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders","volume":"53","author":"Kond\u0115lkov\u00e1","year":"2010","journal-title":"Acta Med (Hradec Kralove)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/srep14273","article-title":"Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression","volume":"5","author":"Yuan","year":"2015","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649812","article-title":"The dual immunomodulatory role of B cells in tumorigenesis: mechanisms, microenvironment crosstalk, and therapeutic implications","volume":"16","author":"Lv","year":"2025","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241263434","article-title":"Insights into a machine learning-based palmitoylation-related gene model for predicting the prognosis and treatment response of breast cancer patients","volume":"23","author":"Zhu","year":"2024","journal-title":"Technol Cancer Res Treat"},{"key":"B57","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molimm.2014.02.016","article-title":"Mast cells, basophils and B cell connection network","volume":"63","author":"Merluzzi","year":"2015","journal-title":"Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.21037\/atm-22-4709","article-title":"Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs","volume":"10","author":"Zhang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/v16071096","article-title":"A review of the bromodomain and extraterminal domain epigenetic reader proteins: function on virus infection and cancer","volume":"16","author":"Wu","year":"2024","journal-title":"Viruses"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1411701111","article-title":"Blockade of oncogenic I\u03baB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors","volume":"111","author":"Ceribelli","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3551","article-title":"Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery","volume":"6","author":"Fu","year":"2015","journal-title":"Oncotarget"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06149-w","article-title":"Circ_0008673 regulates breast cancer Malignancy by miR-153-3p\/CFL2 axis","volume":"305","author":"Zhang","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.12659\/msm.909832","article-title":"Cofilin-2 acts as a marker for predicting radiotherapy response and is a potential therapeutic target in nasopharyngeal carcinoma","volume":"24","author":"Yu","year":"2018","journal-title":"Med Sci Monit"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3892\/or.2011.1447","article-title":"Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues","volume":"26","author":"Wang","year":"2011","journal-title":"Oncol Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010236","article-title":"miR-3189-3p mimics enhance the effects of S100A4 siRNA on the inhibition of proliferation and migration of gastric cancer cells by targeting CFL2","volume":"19","author":"Bian","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.7.1177","article-title":"Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages","volume":"191","author":"Shi","year":"2000","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113908","article-title":"Identifying CTSF and GSTM3 as chemoresistance therapeutic targets in breast cancer through multi-omics MR analysis","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"B68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yexcr.2003.10.002","article-title":"Novel hexad repeats conserved in a putative transporter with restricted expression in cell types associated with growth, calcium exchange and homeostasis","volume":"293","author":"Brasier","year":"2004","journal-title":"Exp Cell Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00690-10","article-title":"The Fowler syndrome-associated protein FLVCR2 is an importer of heme","volume":"30","author":"Duffy","year":"2010","journal-title":"Mol Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1177\/1176935119835522","article-title":"Transcriptomics signature from next-generation sequencing data reveals new transcriptomic biomarkers related to prostate cancer","volume":"18","author":"Alkhateeb","year":"2019","journal-title":"Cancer Inform"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.978786","article-title":"The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia","volume":"10","author":"Su","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011405","article-title":"The HCK\/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance","volume":"138","author":"Yang","year":"2021","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006147","article-title":"A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas","volume":"6","author":"Munshi","year":"2022","journal-title":"Blood Adv"},{"key":"B74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41408-020-0277-6","article-title":"SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas","volume":"10","author":"Munshi","year":"2020","journal-title":"Blood Cancer J"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101348","article-title":"Targeting kinase suppressor of Ras 1 (KSR1) for cancer therapy","volume":"17","author":"Moon","year":"2025","journal-title":"Pharmaceutics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1499376","article-title":"Elevated propionate and its association with neurological dysfunctions in propionic acidemia","volume":"18","author":"Chen","year":"2025","journal-title":"Front Mol Neurosci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.7554\/elife.96925.2","article-title":"Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model","author":"Han","year":"2024","journal-title":"bioRxiv"},{"key":"B78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/his.13204","article-title":"TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma","volume":"71","author":"Loo","year":"2017","journal-title":"Histopathology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12944-024-02237-3","article-title":"Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome","volume":"23","author":"Tan","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2006.08.008","article-title":"CEACAMs: their role in physiology and pathophysiology","volume":"18","author":"Kuespert","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m110.216085","article-title":"Phosphatidylinositol 3'-kinase activity is critical for initiating the oxidative burst and bacterial destruction during CEACAM3-mediated phagocytosis","volume":"286","author":"Buntru","year":"2011","journal-title":"J Biol Chem"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03591.x","article-title":"Immunoreceptor tyrosine-based activation motif phosphorylation during engulfment of Neisseria gonorrhoeae by the neutrophil-restricted CEACAM3 (CD66d) receptor","volume":"49","author":"McCaw","year":"2003","journal-title":"Mol Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1907503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:40:47Z","timestamp":1790055647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1907503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2026.1907503"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1907503","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1907503"}}